Tetrahydrobenzo[d]azepin-2-one derivatives and the use thereof for treating cardiovascular diseases

US7662956B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Nils Griebenow · Milford, US
• Timo Flessner · Wuppertal, DE
• Michael Härter · Wixom, US
• Martin Raabe · Ulm, DE
• Anja Buchmüller · Essen, DE
• Hilmar Bischoff · Wuppertal, DE
• Peter Ellinghaus · Melle, DE
• Peter Kolkhof · Wuppertal, DE

Key dates

• Filing date: Feb 1, 2005
• Grant date: Feb 16, 2010
• Expiry date: Feb 1, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D401/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel tetrahydrobenzo[d]azepin-2-one derivatives, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of cardiovascular disorders, especially of dyslipidaemias, arteriosclerosis, restenosis and ischaemias.